These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 18384998)
1. The efficacy and safety of ceftobiprole in the treatment of complicated skin and skin structure infections: evidence from 2 clinical trials. Deresinski SC Diagn Microbiol Infect Dis; 2008 May; 61(1):103-9. PubMed ID: 18384998 [TBL] [Abstract][Full Text] [Related]
3. Ceftobiprole: an extended-spectrum anti-methicillin-resistant Staphylococcus aureus cephalosporin. Anderson SD; Gums JG Ann Pharmacother; 2008 Jun; 42(6):806-16. PubMed ID: 18477729 [TBL] [Abstract][Full Text] [Related]
4. Ceftobiprole: a novel cephalosporin with activity against Gram-positive and Gram-negative pathogens, including methicillin-resistant Staphylococcus aureus (MRSA). Barbour A; Schmidt S; Rand KH; Derendorf H Int J Antimicrob Agents; 2009 Jul; 34(1):1-7. PubMed ID: 19261449 [TBL] [Abstract][Full Text] [Related]
5. A randomized, double-blind trial comparing ceftobiprole medocaril with vancomycin plus ceftazidime for the treatment of patients with complicated skin and skin-structure infections. Noel GJ; Bush K; Bagchi P; Ianus J; Strauss RS Clin Infect Dis; 2008 Mar; 46(5):647-55. PubMed ID: 18225981 [TBL] [Abstract][Full Text] [Related]
6. Antimicrobial activity of ceftobiprole, a novel anti-methicillin-resistant Staphylococcus aureus cephalosporin, tested against contemporary pathogens: results from the SENTRY Antimicrobial Surveillance Program (2005-2006). Fritsche TR; Sader HS; Jones RN Diagn Microbiol Infect Dis; 2008 May; 61(1):86-95. PubMed ID: 18385000 [TBL] [Abstract][Full Text] [Related]
7. Ceftobiprole: a new cephalosporin for the treatment of skin and skin structure infections. Schirmer PL; Deresinski SC Expert Rev Anti Infect Ther; 2009 Sep; 7(7):777-91. PubMed ID: 19735220 [TBL] [Abstract][Full Text] [Related]
8. Ceftobiprole: a new broad spectrum cephalosporin. El Solh A Expert Opin Pharmacother; 2009 Jul; 10(10):1675-86. PubMed ID: 19527192 [TBL] [Abstract][Full Text] [Related]
9. Ceftobiprole: first cephalosporin with activity against methicillin-resistant Staphylococcus aureus. Vidaillac C; Rybak MJ Pharmacotherapy; 2009 May; 29(5):511-25. PubMed ID: 19397461 [TBL] [Abstract][Full Text] [Related]
10. Results of a double-blind, randomized trial of ceftobiprole treatment of complicated skin and skin structure infections caused by gram-positive bacteria. Noel GJ; Strauss RS; Amsler K; Heep M; Pypstra R; Solomkin JS Antimicrob Agents Chemother; 2008 Jan; 52(1):37-44. PubMed ID: 17954698 [TBL] [Abstract][Full Text] [Related]
13. Ceftobiprole - a case study. Page MG Expert Opin Drug Discov; 2007 Jan; 2(1):115-29. PubMed ID: 23496040 [TBL] [Abstract][Full Text] [Related]
14. What's new and not so new on the antimicrobial horizon? French GL Clin Microbiol Infect; 2008 Dec; 14 Suppl 6():19-29. PubMed ID: 19040463 [TBL] [Abstract][Full Text] [Related]
15. Ceftobiprole: a review of a broad-spectrum and anti-MRSA cephalosporin. Zhanel GG; Lam A; Schweizer F; Thomson K; Walkty A; Rubinstein E; Gin AS; Hoban DJ; Noreddin AM; Karlowsky JA Am J Clin Dermatol; 2008; 9(4):245-54. PubMed ID: 18572975 [TBL] [Abstract][Full Text] [Related]
16. Ceftaroline for complicated skin and skin-structure infections. Nannini EC; Stryjewski ME; Corey GR Expert Opin Pharmacother; 2010 May; 11(7):1197-206. PubMed ID: 20402556 [TBL] [Abstract][Full Text] [Related]
17. In-vitro profile of a new beta-lactam, ceftobiprole, with activity against methicillin-resistant Staphylococcus aureus. Jones ME Clin Microbiol Infect; 2007 Jun; 13 Suppl 2():17-24. PubMed ID: 17488372 [TBL] [Abstract][Full Text] [Related]
18. Cefdinir vs. cephalexin for mild to moderate uncomplicated skin and skin structure infections in adolescents and adults. Giordano PA; Elston D; Akinlade BK; Weber K; Notario GF; Busman TA; Cifaldi M; Nilius AM Curr Med Res Opin; 2006 Dec; 22(12):2419-28. PubMed ID: 17257456 [TBL] [Abstract][Full Text] [Related]
19. Ceftaroline fosamil: a novel broad-spectrum cephalosporin with activity against methicillin-resistant Staphylococcus aureus. Jorgenson MR; DePestel DD; Carver PL Ann Pharmacother; 2011 Nov; 45(11):1384-98. PubMed ID: 22009993 [TBL] [Abstract][Full Text] [Related]
20. Antimicrobial management of complicated skin and skin structure infections in the era of emerging resistance. Lee SY; Kuti JL; Nicolau DP Surg Infect (Larchmt); 2005; 6(3):283-95. PubMed ID: 16201938 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]